Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Alcon (ALC : NYSE)
 
 • Company Description   
Alcon AG is specialized in the medical industry. The Company operates mainly as an eye care device company. Its operating segment consists of Surgical and Vision Care. Surgical portfolio includes technologies and devices for cataract, retinal, refractive surgery as well as advanced technology intraocular lenses to treat cataracts and refractive errors, such as presbyopia and astigmatism. It also includes advanced viscoelastics, surgical solutions, surgical packs and other disposable products for cataract and vitreoretinal surgery. Vision Care segment manufactures contact lenses and lens care products, such as products for dry eye, contact lens care, ocular allergies as well as ocular vitamins and redness relievers. The Company also offers continuing education for eye care professionals. Alcon AG is based in Geneva, Switzerland.

Number of Employees: 24,389

 
 • Price / Volume Information   
Yesterday's Closing Price: $72.68 Daily Weekly Monthly
20 Day Moving Average: 1,220,710 shares
Shares Outstanding: (millions)
Market Capitalization: $ (millions)
Beta: 0.75
52 Week High: $88.78
52 Week Low: $63.92
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -8.48% 3.07%
12 Week -4.14% 5.38%
Year To Date -16.57% 1.30%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
Rue Louis-d`Affry 6
-
Fribourg,V8 1701
CHE
ph: 817-293-0450
fax: 817-916-2652
investor.relations@alcon.com http://www.alcon.com
 
 • General Corporate Information   
Officers
David J. Endicott - Chief Executive Officer
F. Michael Ball - Chairman
F. Michael Ball - Chief Financial Officer
Margaret Buckley - Chief Accounting Officer
Arthur B. Cummings - Director

Peer Information
Alcon (ABMD)
Alcon (DMDS)
Alcon (CPWY.)
Alcon (EQUR)
Alcon (ECIA)
Alcon (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: H01301128
SIC: 3851
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/16/22
Share - Related Items
Shares Outstanding:
Most Recent Split Date: (:1)
Beta: 0.75
Market Capitalization: $ (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.56 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $2.40 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 7.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: 14.40% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/16/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 30.28
Trailing 12 Months: 31.06
PEG Ratio: 2.10
Price Ratios
Price/Book: 1.84
Price/Cash Flow: 15.54
Price / Sales: -
EPS Growth
vs. Year Ago Period: 38.78%
vs. Previous Quarter: 21.43%
Sales Growth
vs. Year Ago Period: 13.42%
vs. Previous Quarter: 1.86%
ROE
03/31/22 - 6.03
12/31/21 - 5.57
09/30/21 - 5.22
ROA
03/31/22 - 4.17
12/31/21 - 3.83
09/30/21 - 3.59
Current Ratio
03/31/22 - 2.18
12/31/21 - 2.18
09/30/21 - 2.23
Quick Ratio
03/31/22 - 1.31
12/31/21 - 1.41
09/30/21 - 1.44
Operating Margin
03/31/22 - 13.57
12/31/21 - 12.82
09/30/21 - 12.26
Net Margin
03/31/22 - 5.38
12/31/21 - 4.53
09/30/21 - 4.11
Pre-Tax Margin
03/31/22 - 5.95
12/31/21 - 5.04
09/30/21 - 4.71
Book Value
03/31/22 - -
12/31/21 - 39.44
09/30/21 - 39.11
Inventory Turnover
03/31/22 - 1.98
12/31/21 - 2.01
09/30/21 - 2.15
Debt-to-Equity
03/31/22 - 0.20
12/31/21 - 0.21
09/30/21 - 0.21
Debt-to-Capital
03/31/22 - 16.73
12/31/21 - 17.08
09/30/21 - 17.24
 

Powered by Zacks Investment Research ©